Overview
Timothy Bergmann practices practicing medicine in Bellinzona, Switzerland.
His clinical expertise encompasses GM1 Gangliosidosis, Gangliosidosis, and Farber Lipogranulomatosis.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Timothy J. Bergmann
Is Timothy J. Bergmann a top-rated expert for GM1 Gangliosidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Timothy J. Bergmann is classified as an Experienced expert for GM1 Gangliosidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Timothy J. Bergmann participate in research or clinical trials?
Yes. Timothy J. Bergmann has published 11 articles and abstracts on conditions like GM1 Gangliosidosis. You can view a list of Timothy J. Bergmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Farber LipogranulomatosisMr. Bergmann isExperienced. Learn about Farber Lipogranulomatosis.
- GangliosidosisMr. Bergmann isExperienced. Learn about Gangliosidosis.
- GM1 GangliosidosisMr. Bergmann isExperienced. Learn about GM1 Gangliosidosis.